Carnosic Acid Induces Antiproliferation and Anti-Metastatic Property of Esophageal Cancer Cells via MAPK Signaling Pathways

Author:

Jiang Sicong1,Qiu Yinda2,Wang Zhaozhen3,Ji Yulong4,Zhang Xiaofang5,Yan Xiaosong6,Zhan Zhiqiang7ORCID

Affiliation:

1. Division of Thoracic and Endocrine Surgery, University Hospitals and University of Geneva, Geneva 41211, Switzerland

2. School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China

3. Department of Clinical Medicine, Jiangxi Health Vocational College of China, Nanchang, Jiangxi, China

4. Jiangxi Key Laboratory of Translational Cancer Research, Jiangxi Cancer Hospital of Nanchang University, Nanchang, Jiangxi, China

5. Department of Pathology, Jiangxi Cancer Hospital of Nanchang University, Nanchang, Jiangxi, China

6. Department of Thoracic Surgery, Jiangxi Cancer Hospital of Nanchang University, Nanchang, Jiangxi, China

7. Department of Oncology, Jiangxi Pingxiang People’s Hospital, Pingxiang, Jiangxi, China

Abstract

Background. Carnosic acid (CA) is a polyphenolic diterpene extracted from rosemary. Reports have shown that CA possesses anticancer activity. However, whether CA inhibits esophageal squamous cell carcinoma, an aggressive type of esophageal cancer, remains untested. Methods. The effects of CA on cell survival, migration, and apoptosis were evaluated by a combination of MTT, colony formation assay, flow cytometry, and Transwell assay. The potential signaling pathways involved were investigated via Western blot assay. Results. CA dose-dependently inhibited cell proliferation, apoptosis, migration, and colony formation. Mechanistically, CA arrested the cell cycle at G2/M phase, promoted cell apoptosis, induced DNA damage, and inhibited the MAPK signaling pathways. Conclusion. Our results suggest that CA is a potential anticancer drug for esophageal squamous cell carcinoma.

Funder

Jiangxi Key Technology R&D Program Foundation

Publisher

Hindawi Limited

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3